Ultrasound detection of fetal aneuploidy in patients with elevated maternal serum alpha-fetoprotein.
Increasing confidence in the ability of high-resolution ultrasound to detect neural tube and ventral wall defects has enabled us to offer a revised risk estimate to the patient with an elevated maternal serum alpha-fetoprotein (MSAFP) level, such that amniocentesis may not be necessary. Recent authors have suggested that a reduced emphasis on follow-up amniocentesis fails to consider an increased risk for chromosomal anomalies in pregnancies with an elevated MSAFP, and that amniocentesis should still be performed. We reviewed our ultrasound findings from patients who underwent amniocentesis for evaluation of an elevated MSAFP and who had a karyotype prepared from the amniotic fluid sample. Four abnormal karyotypes were detected among 313 amniocenteses, and three of these were correctly predicted based on an abnormal ultrasound. The risk of an unexpected fetal aneuploidy after a normal consultative ultrasound in our series was one in 310. This is comparable to the risk of detecting abnormal chromosomes in the fetus of a 32-year-old woman, an age at which amniocentesis is not routinely offered.
Barth
W H
WH
Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, Massachusetts.
Frigoletto
F D
FD
Krauss
C M
CM
MacMillin
M D
MD
Stryker
J M
JM
Benacerraf
B R
BR
D000649:Amniocentesis; D000782:Aneuploidy; D002869:Chromosome Aberrations / Q000000981:diagnostic imaging* / Q000235:genetics; D025063:Chromosome Disorders; D005260:Female; D006801:Humans; D007621:Karyotyping; D011247:Pregnancy / Q000097:blood*; D016216:Ultrasonography, Prenatal; D000509:alpha-Fetoproteins / Q000032:analysis*
D000509:alpha-Fetoproteins